Scientists test drug mix for future lung disease treatment
NCT ID NCT06892756
Summary
This early-stage study aimed to understand how a drug called cyclosporine, often used after organ transplants, might affect the body's processing of an experimental medication for COPD (CHF6001). Thirty healthy volunteers took the COPD drug alone and then again after taking cyclosporine, with a break in between. The goal was to measure the drug levels in the blood to see if the combination is safe to study further in patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medical Centre Comac Medical Ltd
Sofia, 1612, Bulgaria
Conditions
Explore the condition pages connected to this study.